Assessment of safety and efficacy of using granulocyte macrophage colony stimulating factor (GM-CSF) in children to accelerate hematopoietic recovery following bone marrow transplantation. Recombinant human GM-CSF will be given to children prior to and immediately following allogeneic and autologous bone marrow transplants. Clinical and laboratory evidence for safety and efficacy will be gathered.
Showing the most recent 10 out of 455 publications